Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toshihiko Doi

Showing results (11-20 of 247) with videos related to

Pageof 25
Sort By:
Expert Opinion on Pharmacotherapy|July 4, 2014
Tyrosine kinase inhibitors in the treatment of unresectable or metastatic gastrointestinal stromal tumorsToshirou Nishida, Toshihiko Doi, Yoichi Naito
Brain Research Bulletin|September 3, 2004
Neural substrates of the performance of an auditory verbal memory: between-subjects analysis by fMRITadashi Ino, Toshihiko Doi, Toru Kimura, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|June 6, 2013
Correlation between overall survival and other endpoints in clinical trials of second-line chemotherapy for patients with advanced gastric cancerKohei Shitara, Keitaro Matsuo, Kei Muro, et al.
Journal of Cancer Research and Clinical Oncology|May 28, 2013
Progression-free survival and post-progression survival in patients with advanced gastric cancer treated with first-line chemotherapyKohei Shitara, Keitaro Matsuo, Kei Muro, et al.
International Journal of Clinical Oncology|February 28, 2025
Pimitespib in patients with advanced gastrointestinal stromal tumors in Japan: an expanded access programYoichi Naito, Shiro Iwagami, Toshihiko Doi, et al.
Japanese Journal of Clinical Oncology|June 15, 2021
Cost-effectiveness of trifluridine/tipiracil against nivolumab for heavily pretreated metastatic gastric cancer in JapanYusuke Takushima, Ataru Igarashi, Hiroshi Yoshihara, et al.
The Oncologist|April 19, 2015
A phase ib study of safety and pharmacokinetics of ramucirumab in combination with paclitaxel in patients with advanced gastric adenocarcinomasShinya Ueda, Taroh Satoh, Masahiro Gotoh, et al.
Cancer Science|May 13, 2014
Phase I study of olaratumab in Japanese patients with advanced solid tumorsToshihiko Doi, Yan Ma, Aruna Dontabhaktuni, et al.
International Journal of Clinical Oncology|November 20, 2025
Pooled safety analysis of pimitespib for the treatment of patients with advanced gastrointestinal stromal tumorsYukinori Kurokawa, Noboru Yamamoto, Yuko Hirano, et al.
Cancer Science|December 6, 2021
A phase 1 trial of xentuzumab, an IGF-neutralizing antibody, in Japanese patients with advanced solid tumorsToshihiko Doi, Yasutoshi Kuboki, Yoichi Naito, et al.
Pageof 25

Showing results (11-20 of 247) with videos related to

Sort By:
Pageof 25
Expert Opinion on Pharmacotherapy|July 4, 2014
Tyrosine kinase inhibitors in the treatment of unresectable or metastatic gastrointestinal stromal tumorsToshirou Nishida, Toshihiko Doi, Yoichi Naito
Brain Research Bulletin|September 3, 2004
Neural substrates of the performance of an auditory verbal memory: between-subjects analysis by fMRITadashi Ino, Toshihiko Doi, Toru Kimura, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|June 6, 2013
Correlation between overall survival and other endpoints in clinical trials of second-line chemotherapy for patients with advanced gastric cancerKohei Shitara, Keitaro Matsuo, Kei Muro, et al.
Journal of Cancer Research and Clinical Oncology|May 28, 2013
Progression-free survival and post-progression survival in patients with advanced gastric cancer treated with first-line chemotherapyKohei Shitara, Keitaro Matsuo, Kei Muro, et al.
International Journal of Clinical Oncology|February 28, 2025
Pimitespib in patients with advanced gastrointestinal stromal tumors in Japan: an expanded access programYoichi Naito, Shiro Iwagami, Toshihiko Doi, et al.
Japanese Journal of Clinical Oncology|June 15, 2021
Cost-effectiveness of trifluridine/tipiracil against nivolumab for heavily pretreated metastatic gastric cancer in JapanYusuke Takushima, Ataru Igarashi, Hiroshi Yoshihara, et al.
The Oncologist|April 19, 2015
A phase ib study of safety and pharmacokinetics of ramucirumab in combination with paclitaxel in patients with advanced gastric adenocarcinomasShinya Ueda, Taroh Satoh, Masahiro Gotoh, et al.
Cancer Science|May 13, 2014
Phase I study of olaratumab in Japanese patients with advanced solid tumorsToshihiko Doi, Yan Ma, Aruna Dontabhaktuni, et al.
International Journal of Clinical Oncology|November 20, 2025
Pooled safety analysis of pimitespib for the treatment of patients with advanced gastrointestinal stromal tumorsYukinori Kurokawa, Noboru Yamamoto, Yuko Hirano, et al.
Cancer Science|December 6, 2021
A phase 1 trial of xentuzumab, an IGF-neutralizing antibody, in Japanese patients with advanced solid tumorsToshihiko Doi, Yasutoshi Kuboki, Yoichi Naito, et al.
Pageof 25